Department of Radiotherapy and Oncology, Second Affiliated Hospital of Soochow University, 1055 Sanxiang Road, Suzhou, Jiangsu Province, 215004, PR China; Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho- Diseases, Second Affiliated Hospital of Soochow University, 1055 Sanxiang Road, Suzhou, Jiangsu Province, 215004, PR China.
State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Suzhou Medical College of Soochow University/Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, 199 Renai Road, Suzhou Industrial Park, Suzhou, Jiangsu Province, 215123, PR China.
Free Radic Biol Med. 2024 Mar;213:343-358. doi: 10.1016/j.freeradbiomed.2024.01.021. Epub 2024 Jan 24.
Neuronal ferroptosis has been found to contribute to degenerative brain disorders and traumatic and hemorrhagic brain injury, but whether radiation-induced brain injury (RIBI), a critical deleterious effect of cranial radiation therapy for primary and metastatic brain tumors, involves neuronal ferroptosis remains unclear. We have recently discovered that deletion of reprimo (RPRM), a tumor suppressor gene, ameliorates RIBI, in which its protective effect on neurons is one of the underlying mechanisms. In this study, we found that whole brain irradiation (WBI) induced ferroptosis in mouse brain, manifesting as alterations in mitochondrial morphology, iron accumulation, lipid peroxidation and a dramatic reduction in glutathione peroxidase 4 (GPX4) level. Moreover, the hippocampal ferroptosis induced by ionizing irradiation (IR) mainly happened in neurons. Intriguingly, RPRM deletion protected the brain and primary neurons against IR-induced ferroptosis. Mechanistically, RPRM deletion prevented iron accumulation by reversing the significant increase in the expression of iron storage protein ferritin heavy chain (Fth), ferritin light chain (Ftl) and iron importer transferrin receptor 1 (Tfr1), as well as enhancing the expression of iron exporter ferroportin (Fpn) after IR. RPRM deletion also inhibited lipid peroxidation by abolishing the reduction of GPX4 and stearoyl coenzyme A desaturase-1 (SCD1) induced by IR. Importantly, RPRM deletion restored or even increased the expression of nuclear factor, erythroid 2 like 2 (Nrf2) in irradiated neurons. On top of that, compromised cyclic AMP response element (CRE)-binding protein (CREB) signaling was found to be responsible for the down-regulation of Nrf2 and SCD1 after irradiation, specifically, RPRM bound to CREB and promoted its degradation after IR, leading to a reduction of CREB protein level, which in turn down-regulated Nrf2 and SCD1. Thus, RPRM deletion recovered Nrf2 and SCD1 through its impact on CREB. Taken together, neuronal ferroptosis is involved in RIBI, RPRM deletion prevents IR-induced neuronal ferroptosis through restoring CREB-Nrf2/SCD1 pathways.
神经元铁死亡已被发现与退行性脑疾病和创伤性及出血性脑损伤有关,但颅放射治疗原发性和转移性脑肿瘤的关键有害效应——放射性脑损伤(RIBI)是否涉及神经元铁死亡尚不清楚。我们最近发现,肿瘤抑制基因 reprimo(RPRM)缺失可改善 RIBI,其对神经元的保护作用是其潜在机制之一。在这项研究中,我们发现全脑照射(WBI)诱导小鼠脑铁死亡,表现为线粒体形态改变、铁积累、脂质过氧化和谷胱甘肽过氧化物酶 4(GPX4)水平显著降低。此外,电离辐射(IR)诱导的海马铁死亡主要发生在神经元中。有趣的是,RPRM 缺失可保护大脑和原代神经元免受 IR 诱导的铁死亡。机制上,RPRM 缺失通过逆转 IR 后铁储存蛋白 ferritin heavy chain(Fth)、ferritin light chain(Ftl)和铁摄取蛋白 transferrin receptor 1(Tfr1)表达的显著增加,以及增强铁输出蛋白 ferroportin(Fpn)的表达来防止铁积累,从而防止铁积累。RPRM 缺失还通过消除 IR 诱导的 GPX4 和 stearoyl coenzyme A desaturase-1(SCD1)的减少来抑制脂质过氧化。重要的是,RPRM 缺失恢复甚至增加了照射神经元中核因子,红系 2 样 2(Nrf2)的表达。除此之外,还发现环磷酸腺苷反应元件(CRE)结合蛋白(CREB)信号转导受损是照射后 Nrf2 和 SCD1 下调的原因,具体而言,RPRM 与 CREB 结合并在 IR 后促进其降解,导致 CREB 蛋白水平降低,进而下调 Nrf2 和 SCD1。因此,RPRM 缺失通过其对 CREB 的影响恢复了 Nrf2 和 SCD1。总之,神经元铁死亡参与了 RIBI,RPRM 缺失通过恢复 CREB-Nrf2/SCD1 通路来防止 IR 诱导的神经元铁死亡。